10 10 Helston Medical Services Ltd 07123426 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is is that of running a Pharmacy Digita Accounts Production Advanced 6.30.9574.0 true 07123426 2024-04-01 2025-03-31 07123426 2025-03-31 07123426 bus:OrdinaryShareClass1 2025-03-31 07123426 core:CurrentFinancialInstruments 2025-03-31 07123426 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 07123426 core:Goodwill 2025-03-31 07123426 core:FurnitureFittingsToolsEquipment 2025-03-31 07123426 bus:SmallEntities 2024-04-01 2025-03-31 07123426 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 07123426 bus:FilletedAccounts 2024-04-01 2025-03-31 07123426 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 07123426 bus:RegisteredOffice 2024-04-01 2025-03-31 07123426 bus:Director2 2024-04-01 2025-03-31 07123426 bus:Director7 2024-04-01 2025-03-31 07123426 bus:Director8 2024-04-01 2025-03-31 07123426 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 07123426 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 07123426 bus:Agent1 2024-04-01 2025-03-31 07123426 core:Goodwill 2024-04-01 2025-03-31 07123426 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 07123426 core:PlantMachinery 2024-04-01 2025-03-31 07123426 countries:EnglandWales 2024-04-01 2025-03-31 07123426 2024-03-31 07123426 core:Goodwill 2024-03-31 07123426 core:FurnitureFittingsToolsEquipment 2024-03-31 07123426 2023-04-01 2024-03-31 07123426 2024-03-31 07123426 bus:OrdinaryShareClass1 2024-03-31 07123426 core:CurrentFinancialInstruments 2024-03-31 07123426 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 07123426 core:Goodwill 2024-03-31 07123426 core:FurnitureFittingsToolsEquipment 2024-03-31 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 07123426

Helston Medical Services Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2025

 

Helston Medical Services Ltd

Contents

Company Information

1

Directors' Report

2

Balance Sheet

3 to 4

Notes to the Unaudited Financial Statements

5 to 14

 

Helston Medical Services Ltd

Company Information

Directors

Dr Francis Tristram Alan Old

Mrs Amy De'Ath

Dr Judith Anne Preston

Registered office

11 Alverton Terrace
Penzance
Cornwall
TR18 4JH

Accountants

Crane & Johnston C&J Ltd
Chartered Certified Accountants11 Alverton Terrace
Penzance
Cornwall
TR18 4JH

 

Helston Medical Services Ltd

Directors' Report for the Year Ended 31 March 2025

The directors present their report and the financial statements for the year ended 31 March 2025.

Directors of the company

The directors who held office during the year were as follows:

Dr Francis Tristram Alan Old

Mrs Amy De'Ath

Dr Judith Anne Preston

Principal activity

The principal activity of the company is is that of running a Pharmacy

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved by the Board on 17 September 2025 and signed on its behalf by:


Dr Francis Tristram Alan Old
Director

   
     
 

Helston Medical Services Ltd

(Registration number: 07123426)
Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Intangible assets

4

411,588

470,388

Tangible assets

5

1,741

2,323

 

413,329

472,711

Current assets

 

Stocks

6

40,858

50,627

Debtors

7

165,850

154,199

Cash at bank and in hand

 

4,278

44,296

 

210,986

249,122

Creditors: Amounts falling due within one year

8

(246,302)

(251,136)

Net current liabilities

 

(35,316)

(2,014)

Net assets

 

378,013

470,697

Capital and reserves

 

Called up share capital

9

180

180

Retained earnings

377,833

470,517

Shareholders' funds

 

378,013

470,697

 

Helston Medical Services Ltd

(Registration number: 07123426)
Balance Sheet as at 31 March 2025 (continued)

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account and Directors' Report.

Approved and authorised by the Board on 17 September 2025 and signed on its behalf by:
 

Dr Francis Tristram Alan Old
Director

   
     
 

Helston Medical Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
11 Alverton Terrace
Penzance
Cornwall
TR18 4JH
United Kingdom

These financial statements were authorised for issue by the Board on 17 September 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

Helston Medical Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025 (continued)

2

Accounting policies (continued)

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Equipment, fixtures and fittings

25% per annum on reducing balance method

 

Helston Medical Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025 (continued)

2

Accounting policies (continued)

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

written off in equal instalments over its estimated economic life of 20 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Helston Medical Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025 (continued)

2

Accounting policies (continued)

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Helston Medical Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025 (continued)

2

Accounting policies (continued)

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 10 (2024 - 10).

 

Helston Medical Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025 (continued)

4

Intangible assets

Goodwill
 £

Total
£

Cost or valuation

At 1 April 2024

1,119,000

1,119,000

At 31 March 2025

1,119,000

1,119,000

Amortisation

At 1 April 2024

648,612

648,612

Amortisation charge

58,800

58,800

At 31 March 2025

707,412

707,412

Carrying amount

At 31 March 2025

411,588

411,588

At 31 March 2024

470,388

470,388

 

Helston Medical Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025 (continued)

5

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 April 2024

51,232

51,232

At 31 March 2025

51,232

51,232

Depreciation

At 1 April 2024

48,910

48,910

Charge for the year

581

581

At 31 March 2025

49,491

49,491

Carrying amount

At 31 March 2025

1,741

1,741

At 31 March 2024

2,323

2,323

6

Stocks

2025
£

2024
£

Raw materials and consumables

40,858

50,627

 

Helston Medical Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025 (continued)

7

Debtors

Current

2025
£

2024
£

Trade debtors

126,223

124,655

Prepayments

16,526

7,650

Other debtors

23,101

21,894

 

165,850

154,199

 

Helston Medical Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025 (continued)

8

Creditors

Creditors: amounts falling due within one year

Note

2025
£

2024
£

Due within one year

 

Loans and borrowings

10

46,346

39,370

Trade creditors

 

173,766

192,361

Taxation and social security

 

4,404

3,797

Accruals and deferred income

 

2,410

2,425

Other creditors

 

19,376

13,183

 

246,302

251,136

9

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Share capital of £1 each

180

180

180

180

       

10

Loans and borrowings

Current loans and borrowings

2025
£

2024
£

Bank overdrafts

976

-

Other borrowings

45,370

39,370

46,346

39,370

11

Related party transactions

 

Helston Medical Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025 (continued)

11

Related party transactions (continued)

Directors' remuneration

The directors' remuneration for the year was as follows:

2025
£

2024
£

Remuneration

42,815

39,270